177 related articles for article (PubMed ID: 29432743)
1. The inhibition of the effect and mechanism of vascular intimal hyperplasia in Tiam1 knockout mice.
Kou W; Xu X; Ji S; Chen M; Liu D; Wang K; Zhuang J; Yu Q; Zhao Q; Xu Y; Zhang H; Peng W
Biochem Biophys Res Commun; 2018 Feb; 497(1):248-255. PubMed ID: 29432743
[TBL] [Abstract][Full Text] [Related]
2. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
3. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress.
Xue CD; Chen Y; Ren JL; Zhang LS; Liu X; Yu YR; Tang CS; Qi YF
Peptides; 2019 Nov; 121():170131. PubMed ID: 31408662
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
[TBL] [Abstract][Full Text] [Related]
5. Myristoylated Alanine-Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation.
Yu D; Makkar G; Strickland DK; Blanpied TA; Stumpo DJ; Blackshear PJ; Sarkar R; Monahan TS
J Am Heart Assoc; 2015 Oct; 4(10):e002255. PubMed ID: 26450120
[TBL] [Abstract][Full Text] [Related]
6. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway.
Wei P; Tian K; Liu H; Li K; Alam N; Cheng D; Li M; He X; Guo J; Wang R; Wang W; Bai L; Liu E; Xu B; Li Y; Zhao S
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167170. PubMed ID: 38631407
[TBL] [Abstract][Full Text] [Related]
7. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
[TBL] [Abstract][Full Text] [Related]
9. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
10. Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation.
Petri MH; Laguna-Fernandez A; Tseng CN; Hedin U; Perretti M; Bäck M
Int J Cardiol; 2015 Jan; 179():370-2. PubMed ID: 25464488
[No Abstract] [Full Text] [Related]
11. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
[TBL] [Abstract][Full Text] [Related]
12. SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.
Qi W; Li Q; Liew CW; Rask-Madsen C; Lockhart SM; Rasmussen LM; Xia Y; Wang X; Khamaisi M; Croce K; King GL
Diabetologia; 2017 Mar; 60(3):585-596. PubMed ID: 27933336
[TBL] [Abstract][Full Text] [Related]
13. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
[TBL] [Abstract][Full Text] [Related]
14. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
15. Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway.
Sun HJ; Zhao MX; Ren XS; Liu TY; Chen Q; Li YH; Kang YM; Wang JJ; Zhu GQ
Antioxid Redox Signal; 2016 Jun; 24(18):1045-57. PubMed ID: 26952533
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3/DUSP16 axis.
Hou YM; Xu BH; Zhang QT; Cheng J; Zhang X; Yang HR; Wang ZY; Wang P; Zhang MX
J Mol Cell Cardiol; 2024 May; 190():62-75. PubMed ID: 38583797
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor-associated protein regulates carotid intimal hyperplasia through controlling apoptosis of vascular smooth muscle cells.
Yue Y; Ma K; Li Z; Wang Z
Biochem Biophys Res Commun; 2018 Jan; 495(2):2030-2037. PubMed ID: 29247644
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
[TBL] [Abstract][Full Text] [Related]
19. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha.
Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC
Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011
[TBL] [Abstract][Full Text] [Related]
20. Pyrogallol abates VSMC migration via modulation of Caveolin-1, matrix metalloproteinase and intima hyperplasia in carotid ligation mouse.
Ma YD; Thiyagarajan V; Tsai MJ; Lue SI; Chia YC; Shyue SK; Weng CF
Environ Toxicol Pharmacol; 2016 Dec; 48():63-75. PubMed ID: 27768988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
